Insigneo Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,677
| Closed | -$217K | – | 703 |
|
|
2025
Q1 | $217K | Buy |
+2,677
| New | +$217K | 0.02% | 503 |
|
|
2024
Q4 | – | Sell |
-2,751
| Closed | -$272K | – | 693 |
|
|
2024
Q3 | $272K | Buy |
2,751
+308
| +13% | +$30.4K | 0.03% | 472 |
|
|
2024
Q2 | $228K | Sell |
2,443
-3,377
| -58% | -$316K | 0.03% | 473 |
|
|
2024
Q1 | $552K | Sell |
5,820
-199
| -3% | -$18.9K | 0.07% | 247 |
|
|
2023
Q4 | $537K | Buy |
+6,019
| New | +$537K | 0.08% | 230 |
|
|
2023
Q3 | – | Sell |
-3,065
| Closed | -$255K | – | 402 |
|
|
2023
Q2 | $255K | Sell |
3,065
-718
| -19% | -$59.7K | 0.05% | 315 |
|
|
2023
Q1 | $288K | Sell |
3,783
-207
| -5% | -$15.8K | 0.09% | 211 |
|
|
2022
Q4 | $331K | Buy |
+3,990
| New | +$331K | 0.13% | 176 |
|